Logo image of ADN.CA

ACADIAN TIMBER CORP (ADN.CA) Stock Fundamental Analysis

Canada - TSX:ADN - CA0042721005 - Common Stock

17.26 CAD
-0.09 (-0.52%)
Last: 9/17/2025, 7:00:00 PM
Fundamental Rating

4

ADN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 12 industry peers in the Paper & Forest Products industry. ADN has an excellent profitability rating, but there are concerns on its financial health. ADN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ADN had positive earnings in the past year.
ADN had a positive operating cash flow in the past year.
ADN had positive earnings in each of the past 5 years.
In the past 5 years ADN always reported a positive cash flow from operatings.
ADN.CA Yearly Net Income VS EBIT VS OCF VS FCFADN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

ADN's Return On Assets of 2.36% is amongst the best of the industry. ADN outperforms 91.67% of its industry peers.
ADN's Return On Equity of 4.19% is amongst the best of the industry. ADN outperforms 91.67% of its industry peers.
The Return On Invested Capital of ADN (1.63%) is better than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ADN is in line with the industry average of 4.00%.
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROIC 1.63%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ADN.CA Yearly ROA, ROE, ROICADN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ADN's Profit Margin of 16.03% is amongst the best of the industry. ADN outperforms 100.00% of its industry peers.
ADN's Profit Margin has improved in the last couple of years.
ADN has a better Operating Margin (15.01%) than 100.00% of its industry peers.
ADN's Operating Margin has declined in the last couple of years.
ADN has a Gross Margin of 30.11%. This is amongst the best in the industry. ADN outperforms 100.00% of its industry peers.
ADN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
ADN.CA Yearly Profit, Operating, Gross MarginsADN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

ADN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ADN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ADN has more shares outstanding
Compared to 1 year ago, ADN has a worse debt to assets ratio.
ADN.CA Yearly Shares OutstandingADN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADN.CA Yearly Total Debt VS Total AssetsADN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ADN has an Altman-Z score of 1.19. This is a bad value and indicates that ADN is not financially healthy and even has some risk of bankruptcy.
ADN has a worse Altman-Z score (1.19) than 66.67% of its industry peers.
ADN has a debt to FCF ratio of 32.89. This is a negative value and a sign of low solvency as ADN would need 32.89 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 32.89, ADN is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.33 indicates that ADN is not too dependend on debt financing.
ADN has a Debt to Equity ratio (0.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Altman-Z 1.19
ROIC/WACC0.25
WACC6.56%
ADN.CA Yearly LT Debt VS Equity VS FCFADN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.96 indicates that ADN may have some problems paying its short term obligations.
ADN has a Current ratio of 0.96. This is amonst the worse of the industry: ADN underperforms 91.67% of its industry peers.
A Quick Ratio of 0.88 indicates that ADN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.88, ADN is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.88
ADN.CA Yearly Current Assets VS Current LiabilitesADN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

ADN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.45%.
ADN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.80% yearly.
The Revenue for ADN has decreased by -26.79% in the past year. This is quite bad
ADN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.05% yearly.
EPS 1Y (TTM)-56.45%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%-67.39%
Revenue 1Y (TTM)-26.79%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-58.42%

3.2 Future

The Earnings Per Share is expected to decrease by -4.83% on average over the next years.
Based on estimates for the next years, ADN will show a decrease in Revenue. The Revenue will decrease by -1.39% on average per year.
EPS Next Y-24.25%
EPS Next 2Y-7.6%
EPS Next 3Y-10.98%
EPS Next 5Y-4.83%
Revenue Next Year-16.66%
Revenue Next 2Y-0.99%
Revenue Next 3Y-1.39%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADN.CA Yearly Revenue VS EstimatesADN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ADN.CA Yearly EPS VS EstimatesADN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.31, which indicates a rather expensive current valuation of ADN.
75.00% of the companies in the same industry are more expensive than ADN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ADN to the average of the S&P500 Index (27.20), we can say ADN is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 16.05, the valuation of ADN can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ADN indicates a somewhat cheap valuation: ADN is cheaper than 66.67% of the companies listed in the same industry.
ADN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.31
Fwd PE 16.05
ADN.CA Price Earnings VS Forward Price EarningsADN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

75.00% of the companies in the same industry are cheaper than ADN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 92.89
EV/EBITDA 29.35
ADN.CA Per share dataADN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The excellent profitability rating of ADN may justify a higher PE ratio.
ADN's earnings are expected to decrease with -10.98% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.6%
EPS Next 3Y-10.98%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.70%, ADN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.90, ADN pays a better dividend. On top of this ADN pays more dividend than 91.67% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, ADN pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.7%

5.2 History

The dividend of ADN decreases each year by -10.56%.
ADN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of ADN decreased recently.
Dividend Growth(5Y)-10.56%
Div Incr Years1
Div Non Decr Years1
ADN.CA Yearly Dividends per shareADN.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

73.33% of the earnings are spent on dividend by ADN. This is not a sustainable payout ratio.
ADN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP73.33%
EPS Next 2Y-7.6%
EPS Next 3Y-10.98%
ADN.CA Yearly Income VS Free CF VS DividendADN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M
ADN.CA Dividend Payout.ADN.CA Dividend Payout, showing the Payout Ratio.ADN.CA Dividend Payout.PayoutRetained Earnings

ACADIAN TIMBER CORP

TSX:ADN (9/17/2025, 7:00:00 PM)

17.26

-0.09 (-0.52%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-28 2025-10-28
Inst Owners9.34%
Inst Owner ChangeN/A
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap312.75M
Analysts76.67
Price Target19.89 (15.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.7%
Yearly Dividend0.66
Dividend Growth(5Y)-10.56%
DP73.33%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-29 2025-09-29 (0.29)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.32%
Min EPS beat(2)-40.59%
Max EPS beat(2)29.95%
EPS beat(4)2
Avg EPS beat(4)36.33%
Min EPS beat(4)-40.59%
Max EPS beat(4)164.03%
EPS beat(8)5
Avg EPS beat(8)101.8%
EPS beat(12)9
Avg EPS beat(12)176.18%
EPS beat(16)11
Avg EPS beat(16)130.41%
Revenue beat(2)1
Avg Revenue beat(2)-9.79%
Min Revenue beat(2)-31.34%
Max Revenue beat(2)11.76%
Revenue beat(4)1
Avg Revenue beat(4)-7.73%
Min Revenue beat(4)-31.34%
Max Revenue beat(4)11.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.15%
Revenue beat(16)6
Avg Revenue beat(16)-0.65%
PT rev (1m)0%
PT rev (3m)2.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.32%
EPS NY rev (1m)-10%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.09%
Revenue NY rev (1m)-14.38%
Revenue NY rev (3m)-12.77%
Valuation
Industry RankSector Rank
PE 21.31
Fwd PE 16.05
P/S 3.55
P/FCF 92.89
P/OCF 44.74
P/B 0.93
P/tB 0.95
EV/EBITDA 29.35
EPS(TTM)0.81
EY4.69%
EPS(NY)1.08
Fwd EY6.23%
FCF(TTM)0.19
FCFY1.08%
OCF(TTM)0.39
OCFY2.24%
SpS4.86
BVpS18.59
TBVpS18.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROCE 2.27%
ROIC 1.63%
ROICexc 1.64%
ROICexgc 1.65%
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
FCFM 3.82%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ROICexc(3y)2.73%
ROICexc(5y)2.88%
ROICexgc(3y)2.76%
ROICexgc(5y)2.92%
ROCE(3y)3.75%
ROCE(5y)3.95%
ROICexcg growth 3Y0.45%
ROICexcg growth 5Y-5.14%
ROICexc growth 3Y0.47%
ROICexc growth 5Y-5.06%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Debt/EBITDA 7.67
Cap/Depr 328.17%
Cap/Sales 4.11%
Interest Coverage 3.75
Cash Conversion 48.76%
Profit Quality 23.84%
Current Ratio 0.96
Quick Ratio 0.88
Altman-Z 1.19
F-Score3
WACC6.56%
ROIC/WACC0.25
Cap/Depr(3y)780.67%
Cap/Depr(5y)518.79%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.17%
Profit Quality(3y)61.15%
Profit Quality(5y)72.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-56.45%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%-67.39%
EPS Next Y-24.25%
EPS Next 2Y-7.6%
EPS Next 3Y-10.98%
EPS Next 5Y-4.83%
Revenue 1Y (TTM)-26.79%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-58.42%
Revenue Next Year-16.66%
Revenue Next 2Y-0.99%
Revenue Next 3Y-1.39%
Revenue Next 5YN/A
EBIT growth 1Y-48.28%
EBIT growth 3Y2.77%
EBIT growth 5Y1.28%
EBIT Next Year14.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-70.57%
FCF growth 3Y13.98%
FCF growth 5YN/A
OCF growth 1Y-41.26%
OCF growth 3Y28.01%
OCF growth 5YN/A